All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...